HDAC11 inhibitors (FORMA Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHDAC11 inhibitors (FORMA Therapeutics)
Drug Alias NameFT-895
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 11 inhibitors
TargetsHistone deacetylase 11
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesForma Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesForma Therapeutics Holdings Inc
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A